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Ewing’s Sarcoma  
 
Christopher J. Lucasti, BS and Bruce A. Fenderson, PhD  
Department of Pathology, Anatomy & Cell Biology, Thomas Jefferson University 
 
Ewing’s sarcoma is the second most common malignant tumor of the bone 
occurring in children and adolescents. Typically, patients present between the ages of 10 
and 20, with the disease having a slight predilection for males.1 Tumors often arise in the 
mid-shaft with the femur being the most frequently affected bone. The most common 
chromosome translocation, t(11;22)(q24;q12), occurs between the EWS gene and the 
FLI-1 gene. This translocation has been implicated in these aggressive and malignant 
tumors.1–4 Oftentimes, patients present with pain and swelling in the area of the affected 
bone or joint.5 While there has been some improvement in survival for patients that 
present with localized tumors, patients presenting with metastases continue to have a 
poor prognosis.3,6 Current treatment options include surgical resection coupled with 
chemotherapy and radiation therapy. Recent molecular studies have demonstrated some 
promise for the development of targeted gene therapy.4 We present a case of a 16-year 
old boy that presented with leg pain and a mass in his left fibula.  
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